Geratherm Medical AG (FRA:GME)
Germany · Delayed Price · Currency is EUR | Market Cap | 17.75M |
| Revenue (ttm) | 14.61M |
| Net Income (ttm) | 705.18K |
| Shares Out | n/a |
| EPS (ttm) | 0.13 |
| PE Ratio | 25.17 |
| Forward PE | n/a |
| Dividend | 0.10 (2.99%) |
| Ex-Dividend Date | Jul 28, 2025 |
| Volume | n/a |
| Average Volume | 359 |
| Open | 3.150 |
| Previous Close | 3.350 |
| Day's Range | 3.150 - 3.150 |
| 52-Week Range | 2.500 - 5.200 |
| Beta | n/a |
| RSI | 57.27 |
| Earnings Date | Jun 25, 2025 |
About Geratherm Medical AG
Geratherm Medical AG operates as a medical technology company in Germany. It operates through Healthcare Diagnostic, Respiratory, Cardio/Stroke, and Medical Warming Systems segments. The Healthcare Diagnostic segment provides clinical thermometers; and blood pressure monitors. The Respiratory segment develops and manufactures products primarily for pulmonary and cardiopulmonary function diagnostics. The Medical Warming Systems segment offers MRI-compatible incubators for premature babies under the LMT brand. The Cardio/Stroke segment offers str... [Read more]
Financial Performance
In 2024, Geratherm Medical AG's revenue was 14.61 million, a decrease of -33.07% compared to the previous year's 21.82 million. Earnings were 705,175, a decrease of -36.54%.
Financial StatementsNews
EQS-AFR: Geratherm Medical AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
EQS Preliminary announcement financial reports: Geratherm Medical AG / Preliminary announcement on the disclosure of financial statements Geratherm Medical AG: Preliminary announcement of the publicat...